Inter- and Intra-Rater Reliability of a Wearable Inertial Sensor for Spatiotemporal Gait Assessment in Stroke Survivors
1 other identifier
observational
24
1 country
1
Brief Summary
Background and Objective: Stroke frequently impairs gait functionality, leading to significant limitations in functional independence and quality of life. Objective gait analysis is essential for evaluating clinical status and rehabilitation progress. While laboratory-bound, non-wearable systems are considered the gold standard, their high cost, complex infrastructure, and requirement for specialized personnel limit their routine implementation in daily clinical practice. Portable inertial measurement units have emerged as a practical, low-cost alternative for motion analysis outside traditional laboratory settings. However, evidence regarding specific commercial devices in pathological populations remains limited. This study aims to evaluate the inter-rater and intra-rater reliability of the commercially available Baiobit® lumbar-mounted inertial sensor for measuring spatiotemporal gait parameters in stroke survivors. Methodology: A prospective, single-group, repeated-measures design was conducted at a specialized neurorehabilitation clinic (Neuron Clinic, Madrid). A convenience sample of 22 adults diagnosed with subacute or chronic stroke who were able to ambulate independently was included. Gait assessments were performed by two trained evaluators across two separate sessions spaced 24 to 48 hours apart. During each session, the Baiobit® sensor was secured to the participants' sacral region (S1-S2) using an adjustable belt. Participants performed three 10-meter walking trials at their comfortable, self-selected pace for each evaluator. Reliability was quantified using Intraclass Correlation Coefficients (ICC), Standard Error of Measurement (SEM), and Minimal Detectable Change (MDC). Expected Outcomes: It is hypothesized that the Baiobit® inertial sensor will demonstrate adequate relative and absolute inter- and intra-rater reliability across spatiotemporal gait parameters, supporting its viability as an objective monitoring tool in routine stroke rehabilitation clinical settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 14, 2026
CompletedFirst Submitted
Initial submission to the registry
June 10, 2026
CompletedFirst Posted
Study publicly available on registry
June 16, 2026
CompletedJune 16, 2026
June 1, 2026
6 months
June 10, 2026
June 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intra-rater reliability of spatiotemporal gait parameters
Relative and absolute consistency of spatiotemporal gait metrics derived from repeated measurements taken by the same evaluator
Up to 48 hours
Secondary Outcomes (1)
Inter-rater reliability of spatiotemporal gait parameters
Day 1 and day 2
Study Arms (1)
Participants
All the participants included
Eligibility Criteria
The study population consists of a convenience sample of adult stroke survivors receiving outpatient physical therapy and neurorehabilitation care. Participants include individuals with a confirmed diagnosis of either ischemic or hemorrhagic stroke, in both subacute and chronic stages (time since onset greater than one month), who retain the functional capacity to ambulate independently on overground surfaces without physical assistance. All participants are recruited from the outpatient facilities of a specialized neurorehabilitation center (Neuron Clinics) located in Madrid, Spain.
You may qualify if:
- adults aged 18-85 years
- confirmed diagnosis of stroke
- ability to ambulate (FAC \> 4), regardless of foot-up use
- Capacity to walk 10m without stopping and repeat the trials 6 times across the session
- Cognitive ability to understand the study instruction and provide written informed consent
You may not qualify if:
- clinical instability or acute medical conditions that compromise gait safety
- concomitant neurological conditions other than stroke
- severe musculoskeletal disorders that interfere with gait analysis
- balance or coordination impairments secondary to visual or auditory deficits
- recent use of substances or medications that impair bait, balance, or postural control
- pregnancy
- cognitive or behavioral impairments that prevent the proper performance of the test
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Neuron, Spainlead
Study Sites (1)
Neuron Madrid Río
Madrid, Madrid, 28045, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alejandro Herrera Rojas, Physical Therapist
Neuron, Spain
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physical therapist
Study Record Dates
First Submitted
June 10, 2026
First Posted
June 16, 2026
Study Start
October 10, 2025
Primary Completion
April 20, 2026
Study Completion
May 14, 2026
Last Updated
June 16, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ANALYTIC CODE
- Time Frame
- Data will be uploaded once analyzed
- Access Criteria
- Anybody
Database used for the analyses will be published in zenodo website